International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.8352561
Original Article
Ultrasound Evaluation of Median Nerve In Carpal Tunnel Syndrome and Correlation with Nerve Conduction Study
 ,
 ,
 ,
 ,
Published
Sept. 17, 2023
Abstract

Background: This study aimed to investigate the morphology of the Median Nerve in Carpal Tunnel Syndrome (CTS) through ultrasound and establish a correlation with findings from the nerve conduction velocity study.

Methods: After receiving ethical clearance and informed consent, 42 patients were enrolled from the Department of Neurology and underwent assessment in the Department of Radiodiagnosis. These patients underwent laboratory examinations to rule out secondary causes of CTS. Each underwent an ultrasound, with examiners blind to the Nerve Conduction Study (NCS) outcomes. Using NCS as the benchmark, we calculated the sensitivity and specificity of the ultrasound, focusing on the cross-sectional area (CSA) of the Median nerve. Statistical analysis using paired t-tests and the Wilcoxon Sign rank test compared the ultrasound and NCS findings.

Results: 42 CTS patients were studied. When benchmarked against NCS, the ultrasound showed concurrence in diagnosing Median Nerve entrapment neuropathy. There was significant variation between the ultrasound diagnosis and NCS parameters, as evidenced by a significance level of 0.000. Furthermore, the unaffected nerve's CSA proximal to the tunnel inlet displayed minimal variance between the two methods.

Conclusion: Variations in ultrasound metrics exist between CTS patients with moderate NCS irregularities and those with normal NCS. This indicates ultrasound's potential as an additional diagnostic tool, especially for early CTS cases without evident nerve conduction anomalies

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
35 Views
215 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved